The application of the biological treatment in atopic dermatitis: focus on dupilumab
Atopic dermatitis (AD) significantly reduces the quality of life of patients. Skin lesions, itching, and sleep dysfunction lead to impaired social adaptation and work performance.Systemic immunosuppressants are used for the treatment of severe AD. The use of antihistamines and antileukotrienes...
Saved in:
Main Authors: | Yu. S. Smolkin (Author), S. S. Masalskiy (Author), O. Y. Smolkina (Author) |
---|---|
Format: | Book |
Published: |
Association of Paediatric Allergists and Immunologists of Russia (APAIR),
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and hardware evaluation of moisturizing properties and tolerability of a emollient cream with filagrinol ("Admera") in atopic dermatitis in children
by: S. S. Masalskiy, et al.
Published: (2023) -
Clinical case of early debut of food allergy in a child up to 6 months
by: S. S. Masalskiy, et al.
Published: (2023) -
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022) -
Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)